Number of the records: 1  

Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG

  1. 1.
    0360711 - ÚOCHB 2012 RIV US eng J - Journal Article
    Mertlíková-Kaiserová, Helena - Rumlová, Michaela - Tloušťová, Eva - Procházková, Eliška - Holý, Antonín - Votruba, Ivan
    Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG.
    Biochemical Pharmacology. Roč. 82, č. 2 (2011), s. 131-138. ISSN 0006-2952. E-ISSN 1873-2968
    R&D Projects: GA MŠMT 1M0508
    Institutional research plan: CEZ:AV0Z40550506
    Keywords : resistance * acyclic nucleoside phosphonates * PMEG * PMEDAP
    Subject RIV: CE - Biochemistry
    Impact factor: 4.705, year: 2011

    Permanent Link: http://hdl.handle.net/11104/0198197
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.